Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-08-05
Item 5.07
Axalta shareholders voted at a Special General Meeting on August 5, 2026, overwhelmingly approving four proposals: amendment to bye-laws regarding merger approval thresholds (83.58%), approval of the Merger Agreement with AkzoNobel (83.45%), advisory vote on executive compensation in connection with the merger (81.22%), and an adjournment proposal. The shareholder authorization represents a critical milestone for the transformative all-stock merger of equals with AkzoNobel.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-05
The 6-K discloses results of Kamada Ltd.'s Annual General Meeting of Shareholders held on August 5, 2026, where shareholders voted on and approved five proposals: re-election of seven directors, re-election of two external directors for a second three-year term, approval of director option grants, amendment to the 2011 Israeli Share Award Plan, and ratification of the independent auditor (Kost Forer Gabbay & Kasierer). This is a classic shareholder_vote_results disclosure reporting the outcomes of an annual meeting vote.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-05
The filing discloses results of an extraordinary general meeting held on July 29, 2026, where shareholders voted on multiple proposals including the Business Combination Proposal, Merger Proposal, and Advisory Organizational Documents Proposals. The voting tabulations for each proposal are provided with FOR/AGAINST/ABSTAIN/BROKER NON-VOTES counts, which is the core disclosure required under Item 5.07 (Submission of Matters to a Vote of Security Holders). This is material as it confirms shareholder approval of the proposed business combination with Air Water Ventures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-05
Item 5.07
AMSC held its Annual Meeting of Stockholders on July 31, 2026, with shareholders voting on three proposals: election of seven directors to the Board, ratification of RSM US LLP as independent auditor, and an advisory vote on named executive officer compensation.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-05
The 6-K discloses results of an extraordinary general meeting held on August 5, 2026, where shareholders voted on a resolution to increase authorized share capital from US$500,000 to US$12,000,000 by creating additional Class A and Class B ordinary shares. The resolution passed with 98.68% of votes cast in favor. This is a shareholder vote result that materially affects the company's capital structure and would be of interest to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-05
The filing discloses results of a Special Meeting of Stockholders held on August 5, 2026, under Item 5.07. Five proposals were voted upon and approved, including a reverse stock split authorization (1-for-2 to 1-for-200), approval of inducement warrants, and authorization for future offerings of convertible preferred stock and common stock. These shareholder votes are material to investors as they affect capital structure, dilution, and compliance with Nasdaq listing rules.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-05
This 8-K discloses the results of NexGel's 2026 Annual Meeting of Stockholders held on July 31, 2026, under Item 5.07. The filing reports voting outcomes on seven proposals including director elections, approval of convertible note issuances, reincorporation, authorized shares increase, reverse stock split authorization, executive compensation advisory vote, and auditor ratification. These are material shareholder voting results that affect governance and capital structure decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-05
Item 5.07
This is a clear disclosure of shareholder voting results from MSC Income Fund's 2026 annual meeting held on August 5, 2026. The filing reports final vote tallies for two matters: (1) election of five board members, with vote counts for each nominee, and (2) approval of a Below-NAV Share Issuance Proposal. The disclosure explicitly states the voting results and confirms that both proposals passed, making this a material shareholder vote result under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-05
Item 5.07
Universal Corporation held its 2026 Annual Meeting of Shareholders on August 4, 2026, with shareholders voting to elect directors Arthur J. Schick Jr., Gregory A. Trojan, and Jaqueline T. Williams, approving non-binding advisory compensation for named executive officers, and ratifying Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-08-05
Item 5.07
ClearOne stockholders approved by written consent on August 3, 2026, the issuance of 12,500,000 shares (representing more than 20% of outstanding stock and triggering a change of control under Nasdaq rules) and the adoption of the 2026 Omnibus Incentive Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-05
Item 5.07
This is a clear disclosure of shareholder voting results from a special meeting held on August 5, 2026. The filing reports the vote tallies for two proposals: approval of Delaware domestication and approval of an adjournment proposal. The Delaware domestication proposal is material as it involves a change in the company's domicile jurisdiction, which affects corporate governance and legal structure. Item 5.07 is the designated item for shareholder vote results, and the prose explicitly states these are results from the Special Meeting voted upon by shareholders.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-05
The 6-K discloses detailed voting results from Waldencast's August 4, 2026 annual general meeting, including shareholder approval of director re-appointments (Kelly Brookie, Roberto Thompson, Aaron Chatterley), ratification of Deloitte & Touche LLP as auditor, and authorization for share repurchases. This is a classic shareholder_vote_results disclosure with specific vote tallies for each resolution, material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-04
Item 5.07
This is a clear disclosure of shareholder voting results from the Annual Meeting of Stockholders held on July 30, 2026, filed under Item 5.07. The section reports final voting tallies on four proposals: election of seven directors, non-binding executive compensation approval, ratification of Deloitte & Touche LLP as independent auditor, and approval of the 2026 Equity Incentive Plan. All proposals passed. This is a routine but material governance disclosure required by Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-04
Item 5.07
Theriva Biologics held its Annual Meeting of stockholders on August 3, 2026, at which stockholders voted on six proposals: election of four directors, ratification of the auditor, Amendment No. 4 to the 2020 Stock Incentive Plan (increasing authorized shares from 4.5 million to 6.5 million), a charter amendment to increase authorized common stock, approval of warrant exercise issuance, and meeting adjournment. All six proposals passed.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-08-04
The 6-K discloses results of an Extraordinary General Meeting held on August 4, 2026, where shareholders voted on and approved a special resolution authorizing a merger with MTN Group Limited (via Holdings and Merger Sub). The filing reports that all Board-proposed resolutions were approved, including the Merger Agreement and Plan of Merger. This is a classic shareholder vote result disclosure under Item 5.07 equivalent, and the merger approval is material to investors as it represents a change of control transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-08-04
Item 5.07
Shareholders approved an extension of the company's business combination deadline from August 5, 2026 to August 5, 2027 at an extraordinary general meeting on July 30, 2026, with 7,870,808 votes in favor and zero votes against or abstaining. Following the vote, 2,601,058 Class A shares were redeemed at $12.50 per share for $32.5 million, leaving $5.9 million remaining in the Trust Account.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-04
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on August 3, 2026, covering three proposals: election of directors, ratification of auditors, and approval of a reverse stock split with charter amendment. The filing directly corresponds to Item 5.07 and reports the final vote tallies for each matter, which is material to investors as it reflects stockholder decisions on governance and capital structure matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-04
Item 5.07
This is a clear disclosure of shareholder vote results from WhiteHorse Finance's August 3, 2026 annual meeting. The filing reports voting outcomes for two proposals: election of three Class II directors (Stuart Aronson, Jay Carvell, and Rick P. Frier) and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-04
The 6-K discloses the results of three shareholder meetings held on July 31, 2026: a Class A Ordinary Shares meeting, a Class B Ordinary Shares meeting, and an Extraordinary General Meeting. The primary matters voted on were (1) an increase of voting rights for Class B Ordinary Shares from 20 to 200 votes per share, and (2) adoption of amended and restated memorandum and articles of association. All proposals were approved by overwhelming majorities. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the material change to voting rights structure makes it material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-04
The filing discloses results of the 2026 Annual Meeting of Shareholders held on July 30, 2026, with detailed voting outcomes on four proposals: election of six directors, amendment to the 2019 Omnibus Incentive Plan to increase shares by 200,000, ratification of Cherry Bekaert as independent auditor, and an advisory vote on named executive officer compensation. Item 5.07 explicitly presents the vote tallies for each proposal, which is the core disclosure of shareholder voting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-03
Item 5.07
This is a clear disclosure of shareholder vote results from Hawkins Inc.'s annual meeting held July 29, 2026, covering three proposals: election of eight directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of executive compensation. The filing presents detailed voting tallies (For, Against, Abstain, Broker Non-Vote) for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-03
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from Cirrus Logic's Annual Meeting of Stockholders held July 31, 2026. The filing presents final voting tallies for four proposals: election of seven directors, ratification of Ernst & Young LLP as auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2018 Long Term Incentive Plan. All proposals passed with substantial majorities, making this a routine but material governance disclosure that affects investor understanding of board composition and corporate governance approvals.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-03
Item 5.07
This is a clear disclosure of shareholder voting results from 8x8's annual meeting held August 3, 2026, covering four proposals: election of eight directors, advisory vote on executive compensation, ratification of Grant Thornton LLP as independent auditor, and approval of an equity plan amendment. The filing presents final vote tallies for each proposal, confirming all four passed. This is a textbook Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-08-03
EX-99.1
This material fact discloses the results of an Extraordinary Shareholders' Meeting held on August 3, 2026, at which shareholders approved a new share repurchase program authorizing acquisition of up to 5% of LATAM's outstanding shares (28.7 billion shares) over a 5-year period. The disclosure reports the shareholder vote outcome and the specific authorizations granted to the Board of Directors regarding pricing, timing, and execution of the buyback program, which is material to investors' assessment of capital allocation and share dilution dynamics.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-03
Item 5.07
This Item 5.07 discloses the results of a special meeting of stockholders held on August 3, 2026, where shareholders voted on a merger proposal (adoption of the Merger Agreement with Gaia Purchaser, Inc.) and an advisory compensation proposal. The Merger Proposal was approved with overwhelming support (495,937,250 votes for vs. 74,615 against), representing a material acquisition/change of control event. The disclosure of shareholder vote results on a merger is a core shareholder_vote_results event and is material to investors.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-03
The 6-K discloses the results of InMode Ltd.'s Annual General Meeting of Shareholders held on July 30, 2026, reporting that all four proposals were approved: re-election of Dr. Hadar Ron as a Class I director, re-appointment of Kesselman & Kesselman as independent auditors, approval of 6,000 RSUs to non-executive directors, and approval of Special Committee compensation terms. This is a direct disclosure of shareholder vote results under Item 5.07 equivalent, with quorum confirmation (54.71% attendance) and explicit statement that each proposal "was approved."
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-03
Item 5.07
This Item 5.07 disclosure presents the final voting results from Champion Homes' 2026 Annual Meeting of Shareholders held on July 30, 2026, covering three proposals: election of six directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The tabulated vote counts for each proposal are the core content of the filing, which is the defining characteristic of shareholder_vote_results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-03
The filing discloses results of HeartBeam's annual meeting of stockholders held on July 31, 2026, under Item 5.07. It reports voting outcomes for three matters: election of seven directors (all approved), ratification of CBIZ CPAs P.C. as independent auditor (approved), and a proposal to amend the 2022 Equity Incentive Plan to increase authorized shares by 3,000,000 (not approved). This is a standard shareholder vote results disclosure materially affecting investor understanding of governance and capital structure decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-03
Item 5.07
This 8-K Item 5.07 discloses the results of Jasper Therapeutics' 2026 Annual Meeting of Stockholders held on July 31, 2026, including voting outcomes for four proposals: election of two Class II directors (Judith Shizuru and Tom Wiggans), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal, which is the standard disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-03
Item 5.07
This Item 5.07 disclosure reports the final voting results from the Company's Annual General Meeting of Shareholders held on July 28, 2026. The filing presents tabulated results for three matters: (1) election of 11 directors, (2) ratification of Deloitte Ltd. as independent auditors, and (3) advisory vote on named executive officer compensation. This is a classic shareholder_vote_results event, material because it documents the outcome of governance elections and auditor ratification that affect the composition and oversight of the registrant.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-03
The 8-K discloses results of Palatin Technologies' annual meeting of stockholders held on July 28, 2026, under Item 5.07. The filing reports voting outcomes on four matters: election of four directors (Carl Spana, John Prendergast, Alan Dunton, and Arlene Morris), ratification of KPMG LLP as independent auditor, approval of a 260,000-share increase to the 2011 Stock Incentive Plan, and advisory approval of named executive officer compensation. All four proposals passed with substantial majorities. This is a standard shareholder vote results disclosure material to investors' understanding of governance and capital allocation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
This Item 5.07 disclosure reports the results of Ralph Lauren Corporation's Annual Meeting of Stockholders held on July 30, 2026. The filing presents voting results for three matters: (i) election of all director nominees (Class A and Class B), (ii) ratification of Ernst & Young LLP as independent auditor, and (iii) advisory approval of named executive officer compensation. The detailed vote tallies for each director and proposal are the core content of the filing, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
Kyndryl held its Annual Meeting of Stockholders with four proposals voted on: election of six directors (each receiving approximately 90% support), advisory approval of named executive officer compensation (75% approval), approval of the Amended and Restated 2021 Long-Term Performance Plan increasing share authorization by 7.6 million shares (94% approval), and ratification of PricewaterhouseCoopers LLP as independent auditor (97% approval).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-31
Item 5.07
This is a clear disclosure of shareholder vote results from a special meeting held on July 31, 2026. The filing reports voting outcomes on five proposals, including approval of amendments to the Articles of Incorporation (increasing authorized common shares, authorizing preferred and class B common stock, and eliminating super-majority voting rights) and approval of issuance of shares underlying convertible notes. The materiality is evident from the structural changes to the capital structure and voting rights being approved.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
This Item 5.07 filing discloses the results of a special meeting of stockholders held on July 31, 2026, where shareholders voted on and approved three proposals: (1) the Transaction Proposal to approve a Membership Interest Purchase Agreement for Amneal to acquire 100% of Kashiv BioSciences, LLC; (2) the Stock Issuance Proposal to approve issuance of 28,942,108 shares of Common Stock to the sellers; and (3) an Adjournment Proposal (not submitted). The voting results show strong approval with 138,265,079 votes for the Transaction Proposal and 286,714,072 votes for the Stock Issuance Proposal. This is a material acquisition transaction requiring shareholder approval, making the vote results material to investors.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-07-31
EX-99.1
Virax Biolabs Group Ltd is soliciting shareholder approval for three material proposals at an Extraordinary General Meeting scheduled for August 14, 2026: (1) a Share Capital Increase from 2 million to 500 million authorized ordinary shares (a 250x expansion providing significant transactional and financing flexibility), (2) adoption of amended and restated articles of association, and (3) an adjournment proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
This is a clear disclosure of shareholder voting results from the Fund's annual meeting held on July 30, 2026. The filing reports the final vote tallies for two proposals: election of a Class III Trustee (Mary Lee Schneider) and ratification of PricewaterhouseCoopers LLP as independent auditor, with specific vote counts for each proposal. This is the quintessential Item 5.07 disclosure and matches the shareholder_vote_results event type precisely.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
Eagle Materials held its Annual Meeting of Stockholders on July 30, 2026, at which shareholders elected three Class II directors (Margot L. Carter, Michael R. Nicolais, and Mary P. Ricciardello), approved an advisory say-on-pay resolution, approved two charter amendments (board declassification and stockholder special meeting rights), and approved Ernst & Young LLP as independent auditors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-31
Item 5.07
Item 5.07 discloses the results of Seer's 2026 Annual Meeting of Stockholders held on July 28, 2026, including voting outcomes on four matters: (1) election of seven directors with detailed vote tallies for each nominee, (2) ratification of Deloitte & Touche LLP as independent auditor, (3) non-binding advisory vote on named executive officer compensation, and (4) ratification of the Tax Benefit Preservation Plan (which failed). The filing presents the formal voting results tabulated by the independent Inspector of Election, which is the core disclosure required under Item 5.07 for shareholder meeting outcomes.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-31
The 6-K discloses results of an Extraordinary General Meeting held on July 31, 2026, where shareholders voted on and approved material resolutions including an 8-for-1 share consolidation, reclassification of shares into Class A and Class B with differential voting rights (1 vote vs. 50 votes per share), and adoption of amended memorandum and articles of association. The voting results are explicitly presented with vote counts for each resolution. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the capital structure changes are material to investors.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-31
The 6-K discloses the results of the 2026 Annual General Meeting held on July 29, 2026, with detailed voting tallies for 11 proposals including director re-appointments, auditor ratification, share subdivision, name change to "Biddance AI Systems, Inc," and migration from Cayman Islands to British Virgin Islands. These results are material to investors as they reflect shareholder approval of significant corporate governance and structural changes.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-07-31
EX-99.1
This is a notice and proxy statement for a special shareholder meeting scheduled for August 26, 2026, calling shareholders to vote on a reverse share split proposal (1-for-4 to 1-for-40 ratio). While the exhibit is technically a notice/proxy solicitation rather than a report of voting results, it discloses a material shareholder vote on a proposal directly tied to Nasdaq delisting risk—the Company received Listing Qualification Notices on April 2, 2026, for failure to maintain minimum bid price ($1.00) and market value ($35 million) requirements, with a compliance deadline of September 29, 2026. The reverse split is explicitly intended to raise share price to avoid delisting. This is material to investors because delisting would impair liquidity and financing ability. The shareholder vote on this proposal is the substantive disclosure event.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-31
This document is the minutes of Telefônica Brasil's 63rd Extraordinary Shareholders' Meeting held on July 31, 2026, disclosing the results of shareholder votes on six agenda items. The primary material matter is approval of the merger of Fibrasil Infraestrutura e Fibra Ótica S.A. (a wholly-owned subsidiary) into the Company, valued at R$812.6 million, effective August 1, 2026. The document records majority approval of all resolutions including the merger, appraisal report, and ratification of an independent board director. This is a shareholder vote-results disclosure under the taxonomy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of stockholders held on July 27, 2026. The filing presents voting results for six proposals: election of five directors (all passed with >92% support), approval of increased authorized shares (96.59% for), amendment to the 2020 Equity Incentive Plan (80.82% for), advisory say-on-pay vote (83.55% for), ratification of auditors (97.68% for), and other business (84.28% for). The detailed vote tallies and percentages are the core disclosure required under Item 5.07.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 85%
filed 2026-07-31
The 6-K discloses results of an Extraordinary Shareholders' Meeting held July 29, 2026, where shareholders approved three material proposals: (1) delegation to the Board to increase share capital by up to €300 million and issue up to 120 million new shares and convertible bonds; (2) authorization for a reverse stock split at a 1-for-10 to 1-for-20 ratio to maintain Nasdaq compliance. While a corporate name-change proposal was deferred, the approved resolutions grant significant capital-raising and restructuring authority that would materially affect investors' assessment of dilution risk and the company's financial flexibility.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 28, 2026, covering three proposals: election of directors (Susan L. Blount, Bill C. Boor, and Lisa L. Daniels), advisory approval of named executive officer compensation, and ratification of RSM US LLP as independent auditor. The filing directly addresses Item 5.07 requirements and reports final vote tallies for each proposal, making this a textbook shareholder_vote_results event that is material to investors assessing governance and board composition.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-07-31
EX-99.1
This press release discloses the final voting results from ICON plc's Annual General Meeting held on July 31, 2026, including detailed vote tallies for all eight resolutions (director elections, account approval, auditor remuneration authorization, share allotment authority, and share repurchase authorization). The disclosure directly matches the shareholder_vote_results category, which covers results of votes at annual or special meetings of security holders. All resolutions passed, including the election of new directors Barry Balfe, Kevin Egan, and Jeff Elliott, and the re-election of existing directors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
Direct Digital Holdings held its 2026 Annual Meeting of Stockholders on July 31, 2026, with stockholders approving three proposals: election of six directors, ratification of BDO USA as independent auditor, and approval of an amendment to the 2022 Omnibus Incentive Plan increasing authorized shares by 1,200,000 shares.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-30
Item 5.07
This Item 5.07 disclosure reports the results of the 2026 Annual Meeting of Shareholders held on July 29, 2026, with detailed voting tallies for four proposals: election of three Class III directors, ratification of Ernst & Young LLP as independent auditor, advisory say-on-pay vote on named executive officer compensation, and approval of the Fifth Amended and Restated Omnibus Incentive Plan. All four proposals passed with substantial shareholder support, making this a clear shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-30
Item 5.07
Equitable Holdings shareholders voted at a special meeting on July 30, 2026, approving the proposed merger with Corebridge Financial by 97.24% of votes cast (85.84% of outstanding shares) and providing advisory approval of executive compensation in connection with the merger.
View raw filing on EDGAR →